SALIVARY PROFILE AND XEROSTOMIA ON THE ELDERLY IN DEPOK, WEST JAVA, INDONESIA: ANALYSIS OF DEMOGRAPHIC FACTORS AND SYSTEMIC DISEASE
Objective: The objective of this study is to determine the profiles of saliva between sexes, age groups, types of systemic disease, medications, and xerostomia on an elderly population in Depok.
Methods: The study was observational analytical with a cross-sectional study design. Sampling was through a consecutive sampling technique in subjects aged â‰¥60 years living in Depok. Subjects were examined for their salivaâ€™s volume, stimulated and unstimulated salivary analysis, pH, and buffer capacity. Subjects answered fox questionnaires about xerostomia and questionnaires about systemic diseases and medications.
Results: Gender had a significant difference in salivary flow rate but was not significant to pH or buffer capacity. There were no significant differences between types of salivary profile among age, systemic diseases, and medications. The correlation coefficient between xerostomia and stimulated flow rate was higher (0.426) than the unstimulated flow rate (0.303).
Conclusion: The unstimulated and stimulated flow rates exhibited a significant difference between men and women but did not differ significantly between age groups, systemic diseases, or medications. The pH and buffer capacity was not significantly different between sexes, age groups, type of systemic diseases, or medications. Xerostomia was associated with salivary flow rate.
2. Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M, et al. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res 2017;31:e14.
3. de Almeida Pdel V, GrÃ©gio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: A comprehensive review. J Contemp Dent Pract 2008;9:72-80.
4. Tsinti M, Kassi E, Korkolopoulou P, Kapsogeorgou E, Moutsatsou P, Patsouris E, et al. Functional estrogen receptors alpha and beta are expressed in normal human salivary gland epithelium and apparently mediate immunomodulatory effects. Eur J Oral Sci 2009;117:498-505.
5. Prodan A, Brand HS, Ligtenberg AJ, Imangaliyev S, Tsivtsivadze E, van der Weijden F, et al. Interindividual variation, correlations, and sex-related differences in the salivary biochemistry of young healthy adults. Eur J Oral Sci 2015;123:149-57.
6. Cassel C. Geriatric Medicine: An Evidence-Based Approach. 4th ed. New York: Springer; 2002. p. 56-70.
7. Scully C. Drug effects on salivary glands: Dry mouth. Oral Dis 2003;9:165-76.
8. Kharevich O, Shipman B, Goldman BM, Nahon M. Salese to buffer saliva in elderly patients with xerostomia: A pilot study. J Prosthodont 2011;20:135-8.
9. Torres SR, Pedrazas CH, Correia MP, Azevedo MN, Zamprogno T, Silva A Junior, et al. Drugs or disease: Evaluating salivary function in RA patients. Braz Oral Res 2016;30:e106.
10. Kagawa R, Ikebe K, Enoki K, Murai S, Okada T, Matsuda K, et al. Influence of hypertension on pH of saliva in older adults. Oral Dis 2013;19:525-9.
11. Nimma V, Talla H, Poosa M, Gopaladas M, Meesala D, Jayanth L, et al. Influence of hypertension on pH of saliva and flow rate in elder adults correlating with oral health status. J Clin Diagn Res 2016;10:ZC34-6.
12. Kunavina K. Oral Health Assesment of Elderly People Living in The Arkhangelsk Region. Russia: University of Oulu; 2016.
13. Suh KI, Lee JY, Chung JW, Kim YK, Kho HS. Relationship between salivary flow rate and clinical symptoms and behaviours in patients with dry mouth. J Oral Rehabil 2007;34:739-44.
14. Farsi NM. Signs of oral dryness in relation to salivary flow rate, pH, buffering capacity and dry mouth complaints. BMC Oral Health 2007;7:15.